GnRH agonist versus GnRH antagonist in poor ovarian responders: A meta-analysis

Reproductive BioMedicine Online

Volumn 13, Issue 5, 2006, Pages 618-627

  Franco Jr , J G ^a   Baruffi, R L R ^a   Mauri, A L ^a,b   Petersen, C G ^a,b   Felipe, V ^a   Cornicelli, J ^a   Cavagna, M ^c   Oliveira, J B A ^a  

^a Center for Human Reproduction Prof Franco Junior   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

GnRH agonist; GnRH antagonist; Ovarian; Poor responder; Stimulation

Indexed keywords

BUSERELIN ACETATE; CETRORELIX; CHORIONIC GONADOTROPIN; ETHINYLESTRADIOL PLUS LEVONORGESTREL; GANIRELIX; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; HUMAN MENOPAUSAL GONADOTROPIN; LEUPRORELIN; NORDETT; RECOMBINANT FOLLITROPIN; TRIPTORELIN; UROFOLLITROPIN;

ADJUVANT THERAPY; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; DATA BASE; DRUG EFFICACY; DRUG RESPONSE; EFFECT SIZE; EMBASE; EMBRYO TRANSFER; FERTILIZATION IN VITRO; HUMAN; INFERTILITY THERAPY; INFORMATION RETRIEVAL; INTRACYTOPLASMIC SPERM INJECTION; MEDLINE; META ANALYSIS; ONLINE SYSTEM; OOCYTE MATURATION; OVARY HYPERSTIMULATION; PREGNANCY RATE; RISK ASSESSMENT; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW;

EID: 33751111752     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1472-6483(10)60651-7     Document Type: Article

References (30)

1. Akman MA, Erden HF, Tosun SB et al. 2001 Comparison of agonistic flare-up protocol and antagonistic multiple dose protocol in ovarian stimulation of poor responders: results of a prospective randomized trial. Human Reproduction 16, 868-870.
2. Akman MA, Erden HF, Tosun SB et al. 2000 Addition of GnRH-ant in cycles of poor responders undergoing IVF. Human Reproduction 15, 2145-2147.
3. Alviggi C, Clarizia R, Mollo A et al. 2006 Who needs LH in ovarian stimulation? Reproductive BioMedicine Online 12, 599-507.
4. Al-Inany H, Aboulghar M 2002 GnRH-ant in assisted reproduction: a Cochrane Review. Human Reproduction 17, 874-885.
5. Cheung L, Lam P, Lok IH et al. 2005 GnRH-ant versus long GnRH-a protocol in poor responders undergoing IVF: a randomized controlled trial. Human Reproduction 20, 616-621.
6. Craft I, Gorgy A, Hill J et al. 1999 Will GnRH-ants provide new hope for patients considered 'difficult responders' to GnRH-a protocols? Human Reproduction 14, 2959-2962.
7. Cramer DW, Powers DR, Oskowitz SP et al. 1999 Gonadotropin-releasing hormone agonist use in assisted reproduction cycles: the influence of long and short regimens on pregnancy rates. Fertility and Sterility 72, 83-89.
8. D'Amato G, Caroppo E, Pasquadibisceglie A et al. 2004 A novel protocol of ovulation induction with delayed gonadotrophin-releasing hormone antagonist administration combined with high-dose recombinant follicle-stimulating hormone and clomiphene citrate for poor responders and women over 35 years. Fertility and Sterility 81, 1572-1577.
9. De Placido G, Mollo A, Clarizia R et al. 2006 Gonadotropin-releasing hormone (GnRH) antagonist plus recombinant luteinizing hormone vs. a standard GnRH-a short protocol in patients at risk for poor ovarian response. Fertility and Sterility 85, 247-250.
10. Fasouliotis SJ, Laufer N, Sabbagh-Ehrlich S et al. 2003 Gonadotropin-releasing hormone (GnRH)-antagonist versus GnRH-agonist in ovarian stimulation of poor responders undergoing IVF. Journal of Assisted Reproduction and Genetics 20, 455-460.
11. Garcia JE, Padilla SL, Bayati J, Baramki TA 1990 Follicular phase gonadotropin-releasing agonist and human gonadotropins: a better alternative for ovulation induction in in-vitro fertilization. Fertility and Sterility, 53, 302-305.
12. Garcia JE, Jones GS, Acosta AA, Wright G 1983 HMG/HCG follicular maturation for oocytes aspiration: phase II, 1981. Fertility and Sterility 39, 174-179.
13. Garcia-Velasco JA, Isaza V, Vidal C et al. 2001 Human ovarian steroid secretion in vivo: effects of GnRH-a versus antagonist (cetrorelix). Human Reproduction 16, 2533-2539.
14. Hughes EG, Fedorkow DM, Daya S et al. 1992 The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer: a meta-analysis of randomized controlled trials. Fertility and Sterility 58, 888-896.
15. Humaidan P, Bungum M, Andersen YC 2004 Effects of recombinant LH supplementation in women undergoing assisted reproduction with GnRH agonist down-regulation and stimulation with recombinant FSH: an opening study. Reproductive BioMedicine Online 8, 635-643.
16. Janssens RMJ, Brus L, Cahill DJ et al. 2000 Direct ovarian effects and safety aspects of GnRH-as and antagonists. Human Reproduction Update 6, 505-518.
17. Kailasam C, Keay SD, Wilson P et al. 2004 Defining poor ovarian response during IVF cycles, in women aged <40 years, and its relationship with treatment outcome. Human Reproduction 19, 1544-1547.
18. Keay SD, Liversedge NH, Mathur RS, Jenkins JM 1997 Assisted conception following poor ovarian response to gonadotrophin stimulation. Britisth Journal of Obstetrics and Gynaecology 104, 521-527.
19. Lindheim SR. Morales AJ 2003 GnRH-ants followed by a decline in serum estradiol results in adverse outcomes in donor oocyte cycles. Human Reproduction 18, 2023-2031.
20. Marci R, Caserta D, Dolo V et al. 2005 GnRH-ant in IVF poor-responder patients: results of a randomized trial. Reproductive BioMedicine Online 11, 189-193.
21. Malmusi S, La Marca A, Giulini S et al. 2005 Comparison of a gonadotrophin-releasing hormone (GnRH) antagonist and GnRH-a flare-up regimen in poor responders undergoing ovarian stimulation. Fertility and Sterility 84, 402-406.
22. Matikainen T, Ding YQ, Vergara M et al. 1992 Differing responses of plasma bioactive and immunoreactive follicle-stimulating hormone and luteinizing hormone to gonadotrophin-releasing hormone antagonist and agonist treatments in postmenopausal women. Journal of Clinical Endocrinology and Metabolism 75, 820-825.
23. Mulrow CD, Oxman AD (eds) 1996 Cochrane Collaboration Handbook. Cochrane Collaboration, Oxford.
24. Palazón MM, Rubio JM, Sánchez-Gutiérrez M et al. 2005 Tratamiento de pacientes con prognóstico de baja respuesta: comparación de dos protocolos de supresión hipofisaria. Revista Iberoamericana de Fertilidad 22, 123-130.
25. Reissmann T, Felberbaum R, Diedrich K et al. 1995 Development and applications of luteinizing hormone-releasing antagonists in the treatment of infertility: an overview. Human Reproduction 10, 1974-1981.
26. Schmidt DW, Bremner T, Orris JJ et al. 2005 A randomized prospective study of microdose leuprolide versus ganirelix in in vitro fertilization cycles for poor responders. Fertility and Sterility 83, 1568-1571.
27. Scott RT, Navot D 1994 Enhancement of ovarian responsiveness with microdose of gonadotrophin-releasing hormone agonist during ovulation induction for in vitro fertilization. Fertility and Sterility 61, 880-885.
28. Surrey ES, Schoolcraft WB 2000 Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive techniques. Fertility and Sterility 73, 667-676.
29. Surrey ES, Bower J, Hill DM et al. 1998 Clinical and endocrine effects of a microdose GnRH-a flare regimen administered to poor responders who are undergoing in vitro fertilization. Fertility and Sterility 69, 419-424.
30. Tarlatzis BC, Zepiridis L, Grimbizis G, Bontis J 2003 Clinical management of low ovarian response to stimulation for IVF: a systematic review. Human Reproduction Update 9, 61-76.